LONDON--(BUSINESS WIRE)--The global nephrostomy devices market is poised to grow by USD 79.64 million during 2019-2023, progressing at a CAGR of almost 6% during the forecast period. Request free sample pages
Read the 138-page report with TOC on “Nephrostomy Market Analysis Report by Product (Guidewires, Drainage bags, Nephrostomy catheters, Balloon dilators, and Others), End-Users (Hospitals, ASCs, and Others), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2019-2023”.
The market is driven by the growing popularity of percutaneous nephrostomy (PCN) procedures. In addition, the increasing awareness about nephrostomy devices is anticipated to boost the growth of the nephrostomy devices market.
Patients are increasingly preferring minimally invasive surgeries such as percutaneous nephrostomy (PCN) procedures due to various complications associated with traditional open surgeries. PCN is the most common interventional minimally invasive surgical procedure adopted for the treatment of upper urinary tract obstruction. The procedure is also used as the first-line treatment care for patients with kidney stones more than 2 cm in size. The market is also witnessing the development of tubeless PCN procedure that can be performed without the need for nephrostomy tube or ureteral stent devices. Therefore, the increasing popularity of PCN procedures is crucial in driving the growth of the nephrostomy devices market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Nephrostomy Devices Market Companies:
B. Braun Melsungen AG
B. Braun Melsungen AG operates the business across various segments such as Aesculap, OPM, Hospital Care, and Avitum. Nephrofix is the key offering of the company. It is a two-piece set mobile guidewire, which is used to stabilize the catheter during percutaneous nephrostomy procedure.
BD operates the business through segments such as BD Medical, BD Life Sciences, and BD Interventional. The company offers a wide range of nephrostomy devices. X-FORCE N30 Nephrostomy Balloon Dilation Catheter, X-FORCE Renal Sheath, and Malecots are some of its key offerings.
Boston Scientific Corporation
Boston Scientific Corporation operates the business through various segments such as Cardiovascular, Rhythm and Neuro, and MedSurg. The company offers a wide range of nephrostomy devices. Some of the key offerings of the company include Amplatz Type Renal Dilators, NephroMax High-Pressure Nephrostomy Balloon Catheter, and Clear Renal Sheath.
Coloplast Group operates the business through various segments such as ostomy care, continence care, interventional urology, and wound & skin care. Balloon catheters for percutaneous nephrostomy and Amplatz Sheaths are the key products offered by the company.
Cook operates the business through various segments such as Vascular and MedSurg. Ultraxx Nephrostomy Balloon Catheter and Set and Percutaneous Nephrostomy Set are the key products offered by the company.
Olympus Corporation operates the business across segments such as medical business, scientific solutions business, imaging business, and others. EZDilate Balloon Dilators is the key offering of the company. It is used for easy, precise access in either the ureter or kidney with minimized patient trauma during percutaneous nephrolithotomy.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Nephrostomy Devices Product Outlook (Revenue, USD Million, 2019 - 2023)
- Drainage bags
- Nephrostomy catheters
- Balloon dilators
Nephrostomy Devices End-Users Outlook (Revenue, USD Million, 2019 - 2023)
Nephrostomy Devices Regional Outlook (Revenue, USD Million, 2019 - 2023)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Healthcare are:
Global Aortic Stent Grafts Market – Global aortic stent grafts market by geography (Asia, Europe, North America, and ROW) and application (AAA and TAA).
Global Breast Cancer Liquid Biopsy Testing Devices Market – Global breast cancer liquid biopsy testing devices market by geography (Asia, Europe, North America, and ROW) and type (CTCs and circulating nucleic acids and extracellular vesicles).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org